Loading organizations...
§ Venture Capital · Shanghai, Shanghai, China
Private equity and venture capital firm investing in healthcare, technology, and business services startups.
Key people at Huaige Capital.
Huaige Capital was founded in 2016 by Kai Wang (Founder).
Established in either 2016 or 2017, Huaige Capital is a Shanghai-headquartered private equity and venture capital firm specializing in investments across the healthcare, technology, business services, and transport sectors. The firm primarily focuses on venture opportunities, deploying capital into startups at the pre-seed, seed, and Series A stages, with a geographic scope that includes Southeast Asia. Huaige Capital has successfully closed at least three funds since its inception, targeting high-growth potential companies within its core areas of interest. Their last known investment was in Leads Biolabs, announced in April 2019, marking a significant public transaction. Following this, the firm has been classified as inactive due to a lack of further public investments or news, indicating a pause in its market activities.
Huaige Capital was founded in 2016 by Kai Wang (Founder).
Key people at Huaige Capital.
Huaige Capital has 1 tracked investment across 1 company. The latest tracked deal is $1.3M Series A in Juncell Therapeutics in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 15, 2022 | Juncell Therapeutics | $1.3M Series A | — | BioVenture, Huangpu Medical Fund, Huayi Capital, Kaitai Capital |